NASDAQ
Claritas Pharmaceuticals, Inc. (CLAZF) has a free cash flow growth of -306.62% as of Friday, May 29, 2026. This represents a 407.92% decrease compared to its 12-month average of 99.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.